Initiatives to address social determinants of health are likely to positively change the health care landscape, and better patient education can contribute to more favorable care choices says Ken Cohen, MD, director of translational research for Optum Care.
Initiatives to address social determinants of health are likely to positively change the health care landscape, and better patient education can contribute to more favorable care choices says Ken Cohen, MD, director of translational research for Optum Care.
Transcript
How should data be balanced with what the patient thinks they need?
That's a critically important question. Patients continue to conflate more care with better care, and nothing can be farther from the truth. That's the fault of the medical system because we have not done a very good job of educating patients. The solution to that is sophisticated, shared decision-making modules that can actually teach patients in a way that they can understand and participate with what are the real-world outcomes of the care that they're seeking? When you show them that real-world outcome data, by and large, they will choose the correct care. So, we can do this, but we just haven't done an adequate job to date.
What is the role of data currently doing to address disparities of care?
We're not doing enough, but mostly we're not doing enough not because there's not a desire to improve it. I think across the health care system is recognition of the need to improve. The problem is we haven't measured it adequately at this point, so we don't know where to improve. That's changing. Very, very quickly people are adapting to that and beginning to rigorously measure social determinants of health. Once we have an accurate landscape to know where there are deficiencies and how those can be improved, then resources are available to be applied to that, and I think the landscape will change very quickly.
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More